Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37:4–15.

Article  CAS  PubMed  Google Scholar 

Coyle JT, Ruzicka WB, Balu DT. Fifty years of research on schizophrenia: the ascendance of the glutamatergic synapse. Am J Psychiatry. 2020;177:1119–28.

Article  PubMed  PubMed Central  Google Scholar 

Law AJ, Deakin JF. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport. 2001;12:2971–4.

Article  CAS  PubMed  Google Scholar 

Weickert CS, Fung SJ, Catts VS, Schofield PR, Allen KM, Moore LT, et al. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol Psychiatry. 2013;18:1185–92.

Article  CAS  PubMed  Google Scholar 

Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann N Y Acad Sci. 2003;1003:75–93.

Article  CAS  PubMed  Google Scholar 

Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301–8.

Article  CAS  PubMed  Google Scholar 

Moghaddam B, Krystal JH. Capturing the angel in “angel dust”: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull. 2012;38:942–9.

Article  PubMed  PubMed Central  Google Scholar 

Singh T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604:509–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.

Article  Google Scholar 

Ripke S, O’Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trubetskoy V, Pardinas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hall J, Bray NJ. Schizophrenia genomics: convergence on synaptic development, adult synaptic plasticity, or both? Biol Psychiatry. 2022;91:709–17.

Article  CAS  PubMed  Google Scholar 

Lemke JR, Eoli A, Krey I, Popp B, Strehlow V, Wittekind DA, et al. GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy. Mol Psychiatry. 2025;31:374–82.

Article  PubMed  PubMed Central  Google Scholar 

Ohi K, Shimada T, Nitta Y, Kihara H, Okubo H, Uehara T, et al. Specific gene expression patterns of 108 schizophrenia-associated loci in cortex. Schizophr Res. 2016;174:35–38.

Article  PubMed  Google Scholar 

van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635–45.

Article  PubMed  Google Scholar 

Abi-Dargham A. Schizophrenia: overview and dopamine dysfunction. J Clin Psychiatry. 2014;75:e31.

Article  PubMed  Google Scholar 

Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016;17:524–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry. 1998;155:761–7.

Article  CAS  PubMed  Google Scholar 

Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000;97:8104–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain. 2013;136:3242–51.

Article  PubMed  PubMed Central  Google Scholar 

Millard SJ, Bearden CE, Karlsgodt KH, Sharpe MJ. The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity. Neuropsychopharmacology. 2022;47:628–40.

Article  CAS  PubMed  Google Scholar 

Katthagen T, Kaminski J, Heinz A, Buchert R, Schlagenhauf F. Striatal dopamine and reward prediction error signaling in unmedicated schizophrenia patients. Schizophr Bull. 2020;46:1535–46.

Article  PubMed  PubMed Central  Google Scholar 

Morris RW, Vercammen A, Lenroot R, Moore L, Langton JM, Short B, et al. Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol Psychiatry. 2012;17:280–239. 235

Article  Google Scholar 

Corlett PR, Murray GK, Honey GD, Aitken MR, Shanks DR, Robbins TW, et al. Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain. 2007;130(Pt 9):2387–2400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry. 2008;13:267–76. 239

Article  CAS  Google Scholar 

Ermakova AO, Knolle F, Justicia A, Bullmore ET, Jones PB, Robbins TW, et al. Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis. Neuropsychopharmacology. 2018;43:1691–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knolle F, Ermakova AO, Justicia A, Fletcher PC, Bunzeck N, Duzel E, et al. Brain responses to different types of salience in antipsychotic naive first episode psychosis: an fMRI study. Transl Psychiatry. 2018;8:196.

Article  PubMed  PubMed Central  Google Scholar 

Kirschner M, Hager OM, Bischof M, Hartmann MN, Kluge A, Seifritz E, et al. Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia. J Psychiatry Neurosci. 2016;41:152–61.

Article  PubMed  PubMed Central  Google Scholar 

Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001;158:360–9.

Article  CAS  PubMed  Google Scholar 

Matthysse S. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc. 1973;32:200–5.

CAS  PubMed  Google Scholar 

Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatry. 2021;11:355–64.